Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|January 23, 2015
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancerJeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, et al.
Inflammatory Bowel Diseases|December 1, 2011
Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel diseaseBenjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, et al.
The American Journal of Pathology|October 18, 2016
Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn DiseaseGwendalyn J Randolph, Shashi Bala, Jean-François Rahier, et al.
Inflammatory Bowel Diseases|August 25, 2017
Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to InfliximabLoic Guerbau, Romain Gerard, Nicolas Duveau, et al.
Surgical Endoscopy|August 28, 2014
Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomyMircea Chirica, Matthieu Resche-Rigon, Benjamin Pariente, et al.
Inflammatory Bowel Diseases|August 8, 2018
Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based StudyDana Duricova, Hélène Sarter, Guillaume Savoye, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's DiseasePeter Bossuyt, Erwin Dreesen, Jordi Rimola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 3, 2019
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's DiseaseNassim Hammoudi, Dominique Cazals-Hatem, Claire Auzolle, et al.
Gut|February 23, 2019
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrenceMatthieu Allez, Claire Auzolle, Marjolaine Ngollo, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|January 23, 2015
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancerJeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, et al.
Inflammatory Bowel Diseases|December 1, 2011
Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel diseaseBenjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, et al.
The American Journal of Pathology|October 18, 2016
Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn DiseaseGwendalyn J Randolph, Shashi Bala, Jean-François Rahier, et al.
Inflammatory Bowel Diseases|August 25, 2017
Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to InfliximabLoic Guerbau, Romain Gerard, Nicolas Duveau, et al.
Surgical Endoscopy|August 28, 2014
Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomyMircea Chirica, Matthieu Resche-Rigon, Benjamin Pariente, et al.
Inflammatory Bowel Diseases|August 8, 2018
Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based StudyDana Duricova, Hélène Sarter, Guillaume Savoye, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's DiseasePeter Bossuyt, Erwin Dreesen, Jordi Rimola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 3, 2019
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's DiseaseNassim Hammoudi, Dominique Cazals-Hatem, Claire Auzolle, et al.
Gut|February 23, 2019
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrenceMatthieu Allez, Claire Auzolle, Marjolaine Ngollo, et al.
Pageof 9